wicked labz tirzepatide Headline results published this week from TRIUMPH-1 CagriSema vs Tirzepatide: Weight Loss

The peptide did not produce adverse metabolic effects associated with full-length growth hormone, including insulin resistance, glucose intolerance, or IGF-1 elevation

Overall, the researchers found that the APP/PS1 mice treated with Dihexa exhibited a significantly better performance in comparison to the control mice when assessing the number of platform crossings

Furthermore, the study also assessed changes in heart rate and blood pressure from baseline to 24 and 36 weeks using 24-hour ambulatory blood pressure monitoring

Moreover, the ITC did not evaluate the comparative efficacy of semaglutide versus the DPP-4 inhibitor class, which is a commonly used second-line agent